Institutional Fund
First Light Asset Management, LLC
Edina, MNCIK 16000045 filings on record
Portfolio Value
$1.12B
Q1 2026
Holdings
35
Reported positions
New Buys
7
Opened this quarter
QoQ Change
-14.7%
from $1.31B
Portfolio Value Trend
Reported 13F value by quarter
Portfolio value trend — upgrade to see history
UpgradeTop Allocations
Largest positions by weight
- Axogen Inc11.9%
- Palvella Therapeutics Inc Ne11.0%
- Neogenomics Inc6.5%
- Si-Bone Inc6.1%
- Centessa Pharmaceuticals PLC5.6%
- Apogee Therapeutics Inc4.3%
- Other54.7%
Portfolio Holdings
35 positions · Q1 2026
| # | Security | Shares | Value | % Port. | Δ Shares | Activity |
|---|---|---|---|---|---|---|
| 1 | Axogen Inc | 4.00M | $132.61M | 11.9% | −1.23M | Reduced |
| 2 | Palvella Therapeutics Inc Ne | 980.8K | $122.25M | 11.0% | +271.6K | Added |
| 3 | Neogenomics Inc | 9.73M | $72.20M | 6.5% | −305.1K | Reduced |
| 4 | Si-Bone Inc | 5.35M | $67.61M | 6.1% | +320.3K | Added |
| 5 | Centessa Pharmaceuticals PLC | 1.56M | $62.00M | 5.6% | −717.9K | Reduced |
| 6 | Apogee Therapeutics Inc | 576.7K | $48.54M | 4.3% | +291.7K | Added |
| 7 | Amylyx Pharmaceuticals Inc | 3.19M | $44.35M | 4.0% | −164.9K | Reduced |
| 8 | Twist Bioscience Corp | 878.8K | $41.76M | 3.7% | −261.9K | Reduced |
| 9 | Crinetics Pharmaceuticals In | 1.09M | $39.58M | 3.5% | −104.6K | Reduced |
| 10 | 908 Devices Inc | 6.07M | $37.16M | 3.3% | +1.24M | Added |
25 more holdings on Premium
See this fund's complete portfolio, full position changes, and activity history.
Unlock full portfolio